Fucosylation of Cripto is required for its ability to facilitate nodal signaling |
| |
Authors: | Schiffer S G Foley S Kaffashan A Hronowski X Zichittella A E Yeo C Y Miatkowski K Adkins H B Damon B Whitman M Salomon D Sanicola M Williams K P |
| |
Affiliation: | Biogen, Inc., Cambridge, Massachusetts 02142, USA. |
| |
Abstract: | O-linked fucose modification is rare and has been shown to occur almost exclusively within epidermal growth factor (EGF)-like modules. We have found that the EGF-CFC family member human Cripto-1 (CR) is modified with fucose and through a combination of peptide mapping, mass spectrometry, and sequence analysis localized the site of attachment to Thr-88. The identification of a fucose modification on human CR within its EGF-like domain and the presence of a consensus fucosylation site within all EGF-CFC family members suggest that this is a biologically important modification in CR, which functionally distinguishes it from the EGF ligands that bind the type 1 erbB growth factor receptors. A single CR point mutation, Thr-88 --> Ala, results in a form of the protein that is not fucosylated and has substantially weaker activity in cell-based CR/Nodal signaling assays, indicating that fucosylation is functionally important for CR to facilitate Nodal signaling. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|